Cargando…
Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors
OBJECTIVE: We aimed to evaluate whether the systemic inflammatory response index (SIRI) and platelet lymphocyte ratio (PLR) are associated with ovarian malignancy and their diagnostic value. Design: This retrospective study compared SIRI, PLR, cancer antigen 125 (CA125), cancer antigen 153 (CA153),...
Autores principales: | Huang, Huifang, Wu, Kunhai, Chen, Lufei, Lin, Xiaomei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8694276/ https://www.ncbi.nlm.nih.gov/pubmed/34955651 http://dx.doi.org/10.2147/IJGM.S346610 |
Ejemplares similares
-
Letter to the Editor Concerning “Study on the Application of Systemic Inflammation Response Index and Platelet–Lymphocyte Ratio in Ovarian Malignant Tumors” [Letter]
por: Huang, Honglian, et al.
Publicado: (2022) -
Increased neutrophil lymphocyte ratio and platelet lymphocyte ratio in malignant parotid tumors()
por: Kuzucu, İhsan, et al.
Publicado: (2019) -
Neutrophil–Lymphocyte and Platelet–Lymphocyte Ratios in Preoperative Differential Diagnosis of Benign, Borderline, and Malignant Ovarian Tumors
por: Yun, Tae Hui, et al.
Publicado: (2022) -
Combined use of CA125, neutrophil/lymphocyte ratio and platelet/lymphocyte ratio for the diagnosis of borderline and malignant epithelial ovarian tumors
por: Huang, Ke, et al.
Publicado: (2023) -
Study on the Effect of Two Different Transfusion Methods in Neonates with Hyperbilirubinemia Induced by Non-Blood-Group Antibodies
por: Wu, Kunhai, et al.
Publicado: (2021)